FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
DIAMEDIX IS-ANTI-B2 GLYCOPROTEIN I IGG/IGM TEST SYSTEM
K Number: K013628
·
Decision Dec 21, 2001
Classifications
1
FEI Numbers
19
Registration Numbers
19
Same Product Code
45
Applicant Total
68
Review Days
46
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- DIAMEDIX IS-ANTI-B2 GLYCOPROTEIN I IGG/IGM TEST SYSTEM
- K Number
- K013628
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.5660
- Medical Specialty
- Immunology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Diamedix Corp.
- Date Received
- November 5, 2001
- Decision Date
- December 21, 2001
- Product Code
- MSV
- Advisory Committee
- Immunology
- Review Advisory Committee
- IM
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MSV | System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) | FDA class 2 | Immunology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (MSV), ordered by most recent decision date.
Aptiva APS IgA Reagent
FDA 510(k)
FDA Class 2
·Immunology
EliA B2-Glycoprotein I IgA Immunoassay, EliA Cardiolipin IgA Immunoassay
FDA 510(k)
FDA Class 2
·Immunology
ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enhanced B2GP1 IgA/IgG/IgM Antibody ELISA
FDA 510(k)
FDA Class 2
·Immunology
QUANTA Flash B2GP1-Domain1, QUANTA Flash B2GP1-Domain1 Controls, HemosIL AcuStar Anti-B2GPI Domain 1, HemosIL AcuStar Anti-B2GPI Domain 1 Controls
FDA 510(k)
FDA Class 2
·Immunology
QUANTA FLASH ¿2GP1-DOMAIN1; CONTROLS, HEMOSIL ACUSTAR ANTI-¿2GPI DOMAIN1; CONTROLS.
FDA 510(k)
FDA Class 2
·Immunology
ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAY
FDA 510(k)
FDA Class 2
·Immunology
Other Clearances by Diamedix Corp.
| K Number | Device Name | ||
|---|---|---|---|
| K093101 | MAGO 4S | Jan 21, 2011 | Substantially Equivalent |
| K021394 | DIAMEDIX IS-RHEUMATOID FACTOR TEST SYSTEM | Jul 9, 2002 | Substantially Equivalent |
| K013956 | DIAMEDIX IS-ANTI-B2 GLYCOPROTEIN I SCREEN | Jan 8, 2002 | Substantially Equivalent |
| K012450 | DIAMEDIX IS-ANTI-CARDIOLIPIN IGA TEST SYSTEM | Oct 26, 2001 | Substantially Equivalent |
| K012449 | DIAMEDIX IS-ANTI-CARDIOLIPIN IGG/IGM TEST SYSTEM | Oct 26, 2001 | Substantially Equivalent |
| K012795 | DIAMEDIX IS-ANTI-GLIADIN IGG TEST SYSTEM | Sep 28, 2001 | Substantially Equivalent |
| K012797 | DIAMEDIX IS-ANTI-GLIADIN IGA TEST SYSTEM | Sep 28, 2001 | Substantially Equivalent |
| K012053 | DIAMEDIX IS-ANTI-CARDIOLIPIN SCREEN TEST SYSTEM | Aug 20, 2001 | Substantially Equivalent |
| K002262 | DIAMEDIX IS-HSV 1&2 IGM TEST SYSTEM | Nov 28, 2000 | Substantially Equivalent |
| K001875 | DIAMEDIX IS-RUBELLA IGM CAPTURE TEST SYSTEM | Aug 21, 2000 | Substantially Equivalent |